The College of American Pathologists Offers Free Web site -- www.MyBiopsy.org -- to Help Patients Understand this Deadly Disease WHAT: In 2010, more than 159,000 people will die from lung cancer. Bryant Gumbel's announcement that he ...
THE WOODLANDS, Texas, Dec. 14 Seven leading cancer physicians and investigators affiliated with US Oncology Research participated in studies that were presented orally at the 2009 San Antonio Breast Cancer Symposium, held Dec. 9-13 at the Henry B. ...
MORRISTOWN, N.J., Dec. 14 Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced a new program encouraging health professionals to help maintain the bone health of prostate cancer patients who are on long-term androgen deprivation therapy ...
HELSINKI, Dec. 14 Cancer patients in Finland have gained access to more advanced treatments with the introduction of RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR) at the only private radiotherapy clinic in the ...
Westchester Medical Center Physician and Fertility Preservation Expert leads study examining the association of breast cancer genes, breast cancer and infertility VALHALLA, N.Y. , Dec. 11 /PRNewswire-USNewswire/ -- In a study published ...
COLUMBIA, S.C., Dec. 11 African-American women in South Carolina are 37 percent more likely to have cervical cancer than white women and have a death rate that is about 61 percent higher, according to a study by researchers at the University of ...
LONDON and PHILADELPHIA, Dec. 11 In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® ...
SAN ANTONIO, Dec. 11 Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a clinical survey evaluating the impact of the Oncotype DX® Recurrence Score® result on physicians' adjuvant treatment recommendations for ...
WAYNE, N.J. and EMERYVILLE, Calif., Dec. 11 Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase ...
OSLO, December 11 Algeta ASA (OSE: ALGETA), the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin ...
Researchers have discovered that the circadian clock, responsible for regulating daily physiological rhythms, including immune functions, can be utilized to improve the effectiveness of checkpoint inhibitor cancer therapy. These inhibitors prevent ...
Chronic myeloid leukemia (CML), a rare but treatable type of blood cancer , is significantly increasing among young adults aged 30 to 40 in India. CML ( ) affects the bone marrow and is characterized by the uncontrolled growth of white blood ...
Recent research has demonstrated the effectiveness of a novel therapy in reducing the size of challenging prostate and bladder cancers in mice. This therapy involves reprogramming immune cells to enhance their antitumor activity ...
New research indicates that bouts of moderate-to-vigorous intensity exercise could enhance the effectiveness of antibody therapies for treating chronic lymphocytic leukemia ( ). Researchers at the Universities of Birmingham and Bath discovered that a ...
Contrary to previous beliefs, genetics and family history outweigh sun exposure in determining the risk of melanoma, as per a new study from Cleveland Clinic in the US, published in the Journal of the American Academy of Dermatology ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers